Skip to main content
SpringerLink
Log in

Brèves de l’AERIO

AERIO News in Brief

  • Revue de Presse de L’Aerio / Aerio Press Review
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Références

  1. Darby S, McGale P, Correa C, et al. (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378: 1707–1716

    Article  CAS  PubMed  Google Scholar 

  2. Polgár C, Limbergen EV, Pötter R, et al. (2010) Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: Recommendations of the Groupe euro-péen de curiethérapie-European Society for Therapeutic Radiology and Oncology (GECESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 94: 264–273

    Article  PubMed  Google Scholar 

  3. Vaidya JS, Wenz F, Bulsara M, et al. (2013) Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet [Internet] [cited 2014 Jan 4]; Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673613619509

    Google Scholar 

Références

  1. Arora VK, Schenkein E, Murali R, et al. (2013) Glucocorti-coid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade. Cell 155: 1309–1322. doi: 10.1016/j.cell.2013.11.012

    Article  CAS  PubMed  Google Scholar 

  2. Efstathiou E, Titus M, Tsavachidou D, et al. (2012) Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone. J Clin Oncol 30: 637–643. doi: 10.1200/JCO.2010.33.7675

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Fizazi K, Scher HI, Molina A, et al. (2012) Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 13: 983–992. doi: 10.1016/S1470-2045(12)70379-0

    Article  CAS  PubMed  Google Scholar 

  4. Fosså SD, Slee PH, Brausi M, et al. (2001) Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group. J Clin Oncol 19: 62–71

    PubMed  Google Scholar 

  5. Joseph JD, Lu N, Qian J, et al. (2013) A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509. Cancer Discov 3: 1020–1029. doi: 10.1158/2159-8290.CD-13-0226

    Article  CAS  PubMed  Google Scholar 

  6. Korpal M, Korn JM, Gao X, et al. (2013) An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discov 3: 1030–1043. doi: 10.1158/2159-8290.CD-13-0142

    Article  CAS  PubMed  Google Scholar 

  7. Sartor O, Weinberger M, Moore A, et al. (1998) Effect of prednisone on prostate-specific antigen in patients with hormone refractory prostate cancer. Urology 52: 252–256

    Article  CAS  PubMed  Google Scholar 

  8. Scher HI, Fizazi K, Saad F, et al. (2012) Association of baseline corticosteroid with outcomes in a multivariate analysis of the phase 3 affirm study of enzalutamide (ENZA), an androgen receptor signaling inhibitor (ARSI) Abstract 2887 ESMO 2012. Ann Oncol: Official Journal of the European Society for Medical Oncology/ESMO 23: ix294–ix318

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. pour l’AERIO, Nice, France

    F. -G. Riet, S. Rivera & J. Hadoux

Authors
  1. F. -G. Riet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Rivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Hadoux
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. -G. Riet.

About this article

Cite this article

Riet, F.G., Rivera, S. & Hadoux, J. Brèves de l’AERIO. Oncologie 16, 207–210 (2014). https://doi.org/10.1007/s10269-014-2386-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-014-2386-y

Search

Navigation